BENTSUR RON bought NVCT
June 30, 2026 · Form 4 insider transaction
BENTSUR RON bought 12,500 shares of Nuvectis Pharma, Inc. at $20.00 per share, a transaction worth $250.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$20.00
Total value
$250.0K
InsiderBENTSUR RON
Role—
CompanyNuvectis Pharma, Inc. (NVCT)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 30, 2026
Filing dateJuly 1, 2026
Shares owned after3,688,424
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Mr. Bentsur purchased 12,500 shares for $250,000 in the public offering announced on June 29, 2026.; Includes shares of restricted common stock.